{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:15Z","timestamp":1786987695579,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.diagmicrobio.2014.01.015","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T23:20:40Z","timestamp":1390605640000},"page":"77-84","source":"Crossref","is-referenced-by-count":57,"title":["The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?"],"prefix":"10.1016","volume":"79","author":[{"given":"Stijn","family":"Blot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0005","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/CCM.0b013e31821867cc","article-title":"Nursing considerations to complement the Surviving Sepsis Campaign guidelines","volume":"39","author":"Aitken","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0010","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.2006070756","article-title":"Incidence and outcomes in acute kidney injury: a comprehensive population-based study","volume":"18","author":"Ali","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2014.01.015_bb0015","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1086\/653057","article-title":"Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!","volume":"51","author":"Ambrose","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfm744","article-title":"A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients","volume":"23","author":"Bagshaw","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0025","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/cc10262","article-title":"A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance","volume":"15","author":"Baptista","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0030","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/AAC.01615-10","article-title":"Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline","volume":"56","author":"Bhavnani","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2007.01835.x","article-title":"Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units","volume":"14","author":"Blot","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0050","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10096-002-0746-9","article-title":"Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients","volume":"21","author":"Blot","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0055","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1378\/chest.123.4.1208","article-title":"Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study","volume":"123","author":"Blot","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0060","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1097\/01.CCM.0000287587.43801.9C","article-title":"Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia*","volume":"35","author":"Blot","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0065","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/CCM.0b013e31819da98e","article-title":"Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patients","volume":"37","author":"Blot","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.athoracsur.2013.07.090","article-title":"Impact of Perioperative Acute Kidney Injury as a Severity Index for Thirty-Day Readmission After Cardiac Surgery","volume":"97","author":"Brown","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00134-010-1861-1","article-title":"Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis","volume":"36","author":"Brusselaers","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000321488","article-title":"Principles of antibacterial dosing in continuous renal replacement therapy","volume":"30","author":"Choi","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijantimicag.2012.12.015","article-title":"Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion","volume":"41","author":"De Waele","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intens Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0105","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/383320","article-title":"Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia","volume":"189","author":"Drusano","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.31.5.709","article-title":"Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function","volume":"31","author":"Gasser","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0120","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc10441","article-title":"Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams","volume":"15","author":"Goncalves-Pereira","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.ASN.0000110182.14608.0C","article-title":"Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy","volume":"15","author":"Hoste","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0130","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/cc4915","article-title":"RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis","volume":"10","author":"Hoste","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archinte.164.6.637","article-title":"Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia","volume":"164","author":"Houck","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000065221","article-title":"Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen","volume":"22","author":"Jelliffe","year":"2002","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0145","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00134-009-1530-4","article-title":"Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database","volume":"35","author":"Joannidis","year":"2009","journal-title":"Intens Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI200316814","article-title":"Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy","volume":"112","author":"Jumbe","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0155","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO)\u2014work group on acute kidney injury","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-8579(01)00474-5","article-title":"Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients","volume":"19","author":"Kitzes-Cohen","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0165","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2165\/00003495-200363200-00001","article-title":"Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time","volume":"63","author":"Kollef","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0170","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1177\/0091270011416938","article-title":"Tigecycline pharmacokinetics in subjects with various degrees of renal function","volume":"52","author":"Korth-Bradley","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0175","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.ccx.0000144939.24897.71","article-title":"Reflections on the definition, classification, and diagnostic evaluation of acute renal failure","volume":"10","author":"Lameire","year":"2004","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0190","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/01.CCM.0000182798.39709.84","article-title":"Early changes in organ function predict eventual survival in severe sepsis","volume":"33","author":"Levy","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0195","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/AAC.00294-06","article-title":"Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections","volume":"51","author":"Li","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0200","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/0310057X1103900602","article-title":"Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story","volume":"39","author":"Lipman","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0205","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.45.3.845-851.2001","article-title":"Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection","volume":"45","author":"Louie","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1445-5994.2009.02160.x","article-title":"Pitfalls of using estimations of glomerular filtration rate in an intensive care population","volume":"41","author":"Martin","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijantimicag.2007.12.009","article-title":"Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections","volume":"31","author":"McKinnon","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0225","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0230","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2,184 adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0235","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","article-title":"Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability","volume":"44","author":"Pea","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0240","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dkl226","article-title":"Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective","volume":"58","author":"Pea","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1203\/01.PDR.0000156225.93691.4F","article-title":"12-hour versus 24-hour creatinine clearance in critically ill pediatric patients","volume":"58","author":"Pong","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0250","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1097\/CCM.0b013e3181a03961","article-title":"Epidemiology of infection in critically ill patients with acute renal failure","volume":"37","author":"Reynvoet","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0255","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.2174\/138920111798808374","article-title":"The relevance of drug clearance to antibiotic dosing in critically ill patients","volume":"12","author":"Roberts","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0260","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00003088-200645080-00001","article-title":"Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis","volume":"45","author":"Roberts","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0265","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0270","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/CCM.0b013e318180fe62","article-title":"Antibiotic resistance\u2014what's dosing got to do with it?","volume":"36","author":"Roberts","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0275","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MCC.0b013e3283021b3a","article-title":"Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?","volume":"14","author":"Roberts","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0280","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijantimicag.2010.01.022","article-title":"Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?","volume":"35","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0732-8893(90)90095-D","article-title":"Transintestinal elimination of ciprofloxacin","volume":"13","author":"Rohwedder","year":"1990","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0300","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14656566.7.6.639","article-title":"Drug interactions during therapy with three major groups of antimicrobial agents","volume":"7","author":"Shakeri-Nejad","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2110-5820-2-35","article-title":"Does beta-lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring?","volume":"2","author":"Sime","year":"2012","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0310","first-page":"62S","article-title":"Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers","volume":"87","author":"Sorgel","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0315","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0320","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","article-title":"Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study","volume":"38","author":"Tabah","year":"2012","journal-title":"Intens Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0325","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0330","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/AAC.47.6.1853-1861.2003","article-title":"Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function","volume":"47","author":"Tam","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0335","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1128\/AAC.49.12.4920-4927.2005","article-title":"Optimization of meropenem minimum concentration\/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa","volume":"49","author":"Tam","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0340","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dki086","article-title":"Modelling time-kill studies to discern the pharmacodynamics of meropenem","volume":"55","author":"Tam","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0345","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1097\/CCM.0b013e3181a5906f","article-title":"Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study","volume":"37","author":"Thakar","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0350","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/01.CCM.0000224227.70642.4F","article-title":"An assessment of the RIFLE criteria for acute renal failure in hospitalized patients","volume":"34","author":"Uchino","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented renal clearance: implications for antibacterial dosing in the critically ill","volume":"49","author":"Udy","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2011.92","article-title":"Implications of augmented renal clearance in critically ill patients","volume":"7","author":"Udy","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0365","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.11-1671","article-title":"Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations","volume":"142","author":"Udy","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0370","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.10-2371","article-title":"Antibiotic dosing in multiple organ dysfunction syndrome","volume":"139","author":"Ulldemolins","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0375","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcrc.2007.11.011","article-title":"Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study","volume":"23","author":"van Zanten","year":"2008","journal-title":"J Crit Care"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0380","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0385","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijantimicag.2009.11.015","article-title":"Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates\u2014a multicentre, observational survey in critically ill patients","volume":"35","author":"Vogelaers","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0390","first-page":"20","article-title":"Measurements of glomerular filtration in the intensive care unit are only a rough guide to renal function","volume":"35","author":"Wells","year":"1997","journal-title":"S Afr J Surg"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijantimicag.2003.07.010","article-title":"Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing","volume":"23","author":"Xuan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0400","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/AAC.01433-10","article-title":"Protein binding: do we ever learn?","volume":"55","author":"Zeitlinger","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.015_bb0405","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2012.10.015","article-title":"Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock","volume":"41","author":"Zelenitsky","year":"2013","journal-title":"Int J Antimicrob Agents"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T21:29:46Z","timestamp":1565126986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889314000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0732889314000261"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.01.015","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}